Valuation: CK Life Sciences Int'l., (Holdings) Inc.

Market Cap 4.71B 600M 538M 495M 448M 838M 57B 853M 5.9B 2.37B 29.98B 2.25B 2.2B 94.55B P/E 2024
-31.1x
P/E 2025 -42.2x
Enterprise Value 10.73B 1.37B 1.22B 1.13B 1.02B 1.91B 130B 1.94B 13.43B 5.39B 68.3B 5.13B 5.02B 215B EV / Sales 2024
1.71x
EV / Sales 2025 2.57x
Free-Float
25.02%
Yield 2024 *
-
Yield 2025 -
1 day+1.03%
Current month-10.09%
1 month-10.09%
3 months-12.50%
6 months-31.94%
Current year-40.24%
1 week 0.48
Extreme 0.485
0.5
1 month 0.48
Extreme 0.485
0.55
Current year 0.48
Extreme 0.485
0.89
1 year 0.48
Extreme 0.485
1.02
3 years 0.3
Extreme 0.3
1.1
5 years 0.3
Extreme 0.3
1.28
10 years 0.3
Extreme 0.3
1.34
Manager TitleAgeSince
Chief Executive Officer 70 2026-05-07
Director of Finance/CFO 62 2020-08-31
Chief Executive Officer 79 2002-05-31
Director TitleAgeSince
Chairman 62 2002-03-31
Director/Board Member 74 2000-12-31
Director/Board Member 79 2002-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/24/25 Other

Chairperson

2,300,000 0.0239%
11/6/24 Other

Chief Executive Officer

54,000 0.0006%
11/5/24 Other

Chief Executive Officer

116,000 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%0.00%-44.32%-28.99% 600M
+2.28%+1.19%+9.36%-13.31% 264B
+3.85%+1.79%+12.40%-1.58% 82.2B
0.00%+0.73%+13.65%+547.12% 45.83B
+1.77%+5.27%-15.20%+17.63% 47.06B
+0.93%-4.03%+26.73%+7.69% 37.07B
+3.33%-2.38%-3.24%-10.95% 33.28B
-0.39%+1.07%+21.37%+89.56% 31.02B
+0.96%+0.96%-8.21%-7.95% 30B
+1.84%-1.85%-0.98%-23.02% 28.86B
Average +1.56%-0.07%+1.16%+57.62% 60.04B
Weighted average by Cap. +2.03%+0.63%+7.74%+40.03%

Financials

2024 2025
Net sales 5.52B 704M 630M 580M 525M 982M 66.84B 1B 6.92B 2.78B 35.16B 2.64B 2.59B 111B 5.41B 690M 618M 568M 515M 962M 65.48B 980M 6.77B 2.72B 34.44B 2.59B 2.53B 109B
Net income -127M -16.13M -14.45M -13.29M -12.04M -22.51M -1.53B -22.93M -158M -63.62M -806M -60.54M -59.25M -2.54B -187M -23.81M -21.33M -19.62M -17.77M -33.22M -2.26B -33.85M -234M -93.91M -1.19B -89.36M -87.46M -3.75B
Net Debt 5.53B 705M 631M 581M 526M 983M 66.91B 1B 6.92B 2.78B 35.2B 2.64B 2.59B 111B 6.02B 767M 687M 632M 573M 1.07B 72.84B 1.09B 7.54B 3.03B 38.31B 2.88B 2.82B 121B
Projected Income Statement - Annual - CK Life Sciences Int'l., (Holdings) Inc.
Logo CK Life Sciences Int'l., (Holdings) Inc.
CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company is mainly engaged in human health businesses such as research and development, production, promotion and sales of health products and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.
Employees
1,925
Date Price Change Volume
26-10-30 HK$0.4900 +1.03% 992,637
26-10-29 HK$0.4850 -1.02% 1,424,000
26-10-28 HK$0.4900 +1.03% 984,000
26-10-27 HK$0.4850 -2.02% 724,000
26-10-26 HK$0.4950 +1.02% 1,190,000
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - CK Life Sciences Int'l., (Holdings) Inc.